U.S., China, and Germany Dominate Global API CDMO Market Through R&D Leadership
The global active pharmaceutical ingredient (API) CDMO market was valued at USD 108.14 billion in 2024 and is projected to expand at a CAGR of 7.6% from 2025 to 2034. Growth is being fueled by rising demand for outsourced pharmaceutical manufacturing, increasing biologics and specialty drug production, and the need for scalable, high-quality API supply chains. North America and Asia Pacific are...
0 Comments 0 Shares 146 Views 0 Reviews